Skip to main content

Table 2 Perioperative and postoperative outcomes

From: The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly

Variable

Group A (≥ 70 y) (N = 23)

Group B (< 70 y) (N = 58)

P-value

Blood loss (ml)

490.0 ± 443.7

401.4 ± 462.2

0.434

Blood transfusion

5 (21.7)

10 (17.2)

0.752

Extent of liver resection (Major/ Minor)

4/19

12/46

0.737

Operative time (min)

135.4 ± 74.2

128.3 ± 50.3

0.696

Ovellrall

9(39.13)

13(22.42)

0.127

Surgical complication

4 (17.39)

9 (15.52)

0.836

 Bile leak n (%)

1 (4.34)

3 (5.17)

 

 Intraabdominal sepsis n (%)

2 (8.70)

3 (5.17)

 

 Pleural effusion n (%)

0

2 (3.45)

 

 Surgical site infection n (%)

0

1 (1.72)

 

 Bleeding n (%)

1 (4.35)

0

 

Non-surgical complication n (%)

5 (21.74)

4 (6.90)

0.045

 Pneumonia n (%)

2 (8.70)

0

 

 Ascites n (%)

1 (4.35)

3 (5.17)

 

 Atrial fibrillation n (%)

1 (4.35)

1 (1.72)

 

 Liver failure n (%)

1 (4.35)

1 (1.72)

 

90-days mobidity

0

0

 

Clavien classfication

 Grade I-II

6

10

0.367

 Grade III-V

4

1

0.008*

Recurrence time months

32.9 ± 23.7

34.3 ± 33.6

0.721

TACE n (%)

13 (56.5)

28 (48.3)

0.624

Postoperative complications n (%)

8 (34.8)

11 (19.0)

0.152

Postoperative hospital stay (d)

13.4 ± 7.5

9.5 ± 4.0

0.003*

  1. TACE transarterial chemoembolization (TACE)